Journal of the Korean Society of Radiology (대한영상의학회지)

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

주사용 요오드화 조영제 및 MRI용 가돌리늄 조영제 유해 반응에 대한 한국 임상진료지침: 개정된 임상적 합의 및 권고안(2022년 제3판)

  • Se Won Oh (Department of Radiology, The Catholic University of Korea, Eunpyeong St. Mary's Hospital) ;
  • So Young Park (Department of Internal Medicine, Chung-Ang University College of Medicine) ;
  • Hwan Seok Yong (Department of Radiology, Cardiothoracic Division, Korea University Guro Hospital) ;
  • Young Hun Choi (Department of Radiology, Seoul National University Hospital) ;
  • Min Jae Cha (Department of Radiology, Chung-Ang University College of Medicine) ;
  • Tae Bum Kim (Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Ji Hyang Lee (Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Sae Hoon Kim (Department of Internal Medicine, Seoul National University Bundang Hospital) ;
  • Jae Hyun Lee (Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Gyu Young Hur (Department of Internal Medicine, Korea University College of Medicine) ;
  • Jae Yeon Hwang (Department of Radiology, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, College of Medicine, Pusan National University) ;
  • Sejoong Kim (Division of Nephrology, Department of Internal Medicine, Seoul National University Bundang Hospital) ;
  • Hyo Sang Kim (Division of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan) ;
  • Ji Young Ryu (Division of Nephrology, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital) ;
  • Miyoung Choi (Division of Health Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency) ;
  • Chi-Hoon Choi (Department of Radiology, Chungbuk National University Hospital, College of Medicine and Medical Research Institute, Chungbuk National University)
  • 오세원 (가톨릭대학교 은평성모병원 영상의학과) ;
  • 박소영 (중앙대학교 의과대학 내과학교실) ;
  • 용환석 (고려대학교 구로병원 영상의학과) ;
  • 최영훈 (서울대학교병원 영상의학과) ;
  • 차민재 (중앙대학교 의과대학 영상의학과) ;
  • 김태범 (울산대학교 의과대학 서울아산병원 알레르기내과) ;
  • 이지향 (울산대학교 의과대학 서울아산병 신장내과) ;
  • 김세훈 (분당서울대학교병원 신장내과) ;
  • 이재현 (연세대학교 의과대학 내과학교실 알레르기 및 면역학교실) ;
  • 허규영 (고려대학교 의과대학 내과학교실) ;
  • 황재연 (부산대학교 의과대학 양산부산대학교병원 의생명과학기술융합연구소 영상의학과) ;
  • 김세중 (분당서울대학교병원 신장내과) ;
  • 김효상 (울산대학교 의과대학 서울아산병 신장내과) ;
  • 류지영 (한림대학교 동탄성심병원 신장내과) ;
  • 최미영 (한국보건의료연구원 보건의료근거연구본부) ;
  • 최치훈 (충북대학교병원 영상의학과, 충북대학교 의과대학 의과학연구소)
  • Received : 2022.03.09
  • Accepted : 2022.03.19
  • Published : 2022.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

The Korean Society of Radiology and Medical Guidelines Committee amended the existing 2016 guidelines to publish the "Korean Clinical Practice Guidelines for Adverse Reactions to Iodide Contrast for Injection and Gadolinium Contrast for MRI: The Revised Clinical Consensus and Recommendations (2022 Third Edition)." Expert members recommended and approved by the Korean Society of Radiology, the Korean Academy of Asthma, Allergy and Clinical Immunology, and the Korean Nephrology Society participated together. According to the expert consensus or systematic literature review, the description of the autoinjector and connection line for the infection control while using contrast medium, the acute adverse reaction, and renal toxicity to iodized contrast medium were modified and added. We would like to introduce the revised contents.

대한영상의학회 진료지침위원회는 기존의 2016년 진료지침을 개정하여 '주사용 요오드화 조영제 및 MRI용 가돌리늄 조영제 유해 반응에 대한 한국 임상진료지침: 개정된 임상적 합의 및 권고안(2022년 제3판)'을 제작하였다. 대한영상의학회와 대한천식알레르기학회, 대한신장학회에세 추천 및 승인된 전문가 위원들이 함께 참여하였고, 전문가 합의 또는 체계적 문헌 고찰을 기반으로, 조영제를 사용 시 감염관리를 위한 자동주입기 및 연결선에 대한 기술과 요요드화 조영제에 대한 급성 유해반응 및 신장 유해반응에 대한 내용들을 수정 및 추가하였다. 이에 개정된 내용을 소개하고자 한다.

Keywords

Acknowledgement

The medical guideline committee included Korean Society of Radiology, the Korean Academy of Asthma, Allergy and clinical Immunology, and the Korean Nephrology Society. We thank Chng-Hee Cho for her contributions to data acquisition and support.

References

  1. Jung SE. Prevention of infection from contrast agents. J Korean Med Assoc 2020;63:141-144
  2. Buerke B, Mellmann A, Stehling C, Wessling J, Heindel W, Juergens KU. Microbiologic contamination of automatic injectors at MDCT: experimental and clinical investigations. AJR Am J Roentgenol 2008;191:W283-W287
  3. Buerke B, Puesken M, Mellmann A, Seifarth H, Heindel W, Wessling J. Microbiologic contamination and time efficiency of use of automatic MDCT injectors with prefilled syringes: results of a clinical investigation. AJR Am J Roentgenol 2010;194:299-303
  4. Buerke B, Puesken M, Mellmann A, Schuelke C, Knauer A, Heindel W, et al. Automatic MDCT injectors: hygiene and efficiency of disposable, prefilled, and multidosing roller pump systems in clinical routine. AJR Am J Roentgenol 2011;197:W226-W232
  5. Lee DH, Jung KY, Choi YH. Use of maximal sterile barrier precautions and/or antimicrobial-coated catheters to reduce the risk of central venous catheter-related bloodstream infection. Infect Control Hosp Epidemiol 2008;29:947-950
  6. Yoon SH, Lee SY, Kang HR, Kim JY, Hahn S, Park CM, et al. Skin tests in patients with hypersensitivity reaction to iodinated contrast media: a meta-analysis. Allergy 2015;70:625-637
  7. Kwon OY, Lee JH, Park SY, Seo B, Won HK, Kang Y, et al. Novel strategy for the prevention of recurrent hypersensitivity reactions to radiocontrast media based on skin testing. J Allergy Clin Immunol Pract 2019;7:2707-2713
  8. Trautmann A, Brockow K, Behle V, Stoevesandt J. Radiocontrast media hypersensitivity: skin testing differentiates allergy from nonallergic reactions and identifies a safe alternative as proven by intravenous provocation. J Allergy Clin Immunol Pract 2019;7:2218-2224
  9. Torres MJ, Trautmann A, Bohm I, Scherer K, Barbaud A, Bavbek S, et al. Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity. Allergy 2021;76:1325-1339
  10. International Society of Nephrology. Section 2: AKI definition. Kidney Int Suppl (2011) 2012;2:19-36
  11. American College of Radiology. Manual on contrast media. Available at: https://www.acr.org/Clinical-Resources/Contrast-Manual. Accessed April 22, 2021
  12. Baumgarten DA, Ellis JH. Contrast-induced nephropathy: contrast material not required? AJR Am J Roentgenol 2008;191:383-386
  13. Davenport MS, Cohan RH, Khalatbari S, Ellis JH. The challenges in assessing contrast-induced nephropathy: where are we now? AJR Am J Roentgenol 2014;202:784-789
  14. McDonald JS, McDonald RJ, Carter RE, Katzberg RW, Kallmes DF, Williamson EE. Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology 2014;271:65-73
  15. Newhouse JH, RoyChoudhury A. Quantitating contrast medium-induced nephropathy: controlling the controls. Radiology 2013;267:4-8
  16. Nyman U, Ahlkvist J, Aspelin P, Brismar T, Frid A, Hellstrom M, et al. Preventing contrast medium-induced acute kidney injury. Side-by-side comparison of Swedish-ESUR guidelines. Eur Radiol 2018;28:5384-5395
  17. Too CW, Ng WY, Tan CC, Mahmood MI, Tay KH. Screening for impaired renal function in outpatients before iodinated contrast injection: comparing the Choyke questionnaire with a rapid point-of-care-test. Eur J Radiol 2015;84:1227-1231
  18. Nijssen EC, Nelemans PJ, Rennenberg RJ, Theunissen RA, van Ommen V, Wildberger JE. Prophylaxis in highrisk patients with eGFR < 30 mL/min/1.73 m2: get the balance right. Invest Radiol 2019;54:580-588
  19. Trivedi H, Foley WD. Contrast-induced nephropathy after a second contrast exposure. Ren Fail 2010;32:796-801
  20. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996;334:574-579
  21. Dunn CJ, Peters DH. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs 1995;49:721-749
  22. Sirtori CR, Pasik C. Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. Pharmacol Res 1994;30:187-228
  23. Wiholm BE, Myrhed M. Metformin-associated lactic acidosis in Sweden 1977-1991. Eur J Clin Pharmacol 1993;44:589-591